Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Immunosuppressive Antibodies


Published on

Published in: Technology, Health & Medicine
  • Be the first to comment

Immunosuppressive Antibodies

  1. 1. By: Dr. Vahid NikouiEmail:
  2. 2. *Milstein & Kohler in 1975*Hybridoma*Antibody-forming cells fused to immortal plasmacytoma cells*Hybrid cells that are stable and produce the required antibody can be subcloned for mass culture for antibody production
  3. 3. Antilymphocyte (ALG) and antithymocyte (ATG) globulins* Obtained from the serum of animals* Steroid-resistant acute rejection reaction and grave aplastic anemia treatment, delayed hypersensitivity and the graft-versus-host disease (GVHD)* As an adjuvant in ciclosporin therapy* Inhibit T lymphocytes and cause their lysis: * Complement-mediated cytolysis * Cell-mediated opsonization followed by removal of reticuloendothelial cells from the circulation in the spleen and liver
  4. 4. *There are two preparations available to the market: * Atgam ,obtained from horse serum * Thymoglobuline obtained from rabbit serum*High immunogenicity, acute reaction to the treatment, fever and even anaphylaxis (type III)
  5. 5. *High dose (2g/kg)*Decreased T-Helper and increased T-Suppressor*In different autoimmune diseases
  6. 6. * Rh0(D) IgG* Mother Rh- and fetus Rh+* Labor, abortion or ectopic pregnancy (sensitization)* Next pregnancy: Erythroblastosis (heamolytic)* Rho Ab injection to mother 24-72 hrs after the labor of a Rh+ newborn
  7. 7. *IGIV*From selected donors*Abs against viruses and toxins
  8. 8. *Directed towards exactly defined antigens*Fewer side-effects
  9. 9. * Humanization* Fc* Murine * -onab* Humanized * -umab or -zumab* Chimeric * -imab or -ximab* Recombinant Pr attached to Abs * -cept
  10. 10. * Murine anti-CD3* Prevents T-cell activation and proliferation* One of the most potent immunosuppressive substances* To control the steroid- and/or polyclonal antibodies-resistant acute rejection episodes* Also used prophylactically in transplantations* Inthe first few administrations this binding non-specifically activates T-cells, leading to a serious syndrome 30 to 60 minutes later. It is characterized by fever, myalgia, headache, and arthralgia.
  11. 11. *A recombinant Pr that attached to Fc part of human IgG1*Binds to CD2 on T cells*Psoriasis
  12. 12. *Humanized antibody*Binds to CD11a (α part of LFA-1) on T cells*Prevents the interaction between LFA-1 and ICAM-1 on APCs*Severe Psoriasis
  13. 13. *Humanized IgG1*Binds to CD52 on B cells, T cells and NK*Chorionic lymphocytic leukemia
  14. 14. *Chimeric IgG1*Binds to CD20 on B cells*Non-Hodgkin`s lymphoma
  15. 15. *Chimeric mouse/human antibody*1998*Binds to IL-2a receptors α chain (CD25)*Prophylaxis of the acute organ rejection after kidney transplantation
  16. 16. *Humanized antibody*1998*Binds to IL-2a receptors α chain (CD25)*Prophylaxis of the acute organ rejection after kidney transplantation
  17. 17. *Suppression of IL-1 and IL-6 and leukocyte migration
  18. 18. *Completely Human IgG1*Rheumatoid arthritis*Toxicity: lymphoma
  19. 19. *A recombinant Pr that attached to Fc part of human IgG1*Rheumatoid arthritis*Toxicity: lymphoma
  20. 20. *Chimeric IgG1*Rheumatoid arthritis*Crohn`s disease*Toxicity: lymphoma
  21. 21. *A recombinant Pr that attached to Fc part of human IgG*Binds to CD80 or CD86 on APCs*Inhibition of contact to CD28 on T cells*Rheumatoid arthritis
  22. 22. *Humanized Ab against IgE*Prevents IgE attachment to Fc receptors on basophils and mast cells*Prevents resealing of type I allergic mediators